Literature DB >> 8067050

The immunopathogenesis of equine infectious anemia virus.

D C Sellon1, F J Fuller, T C McGuire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8067050      PMCID： PMC7134051          DOI： 10.1016/0168-1702(94)90038-8

Source DB:  PubMed          Journal:  Virus Res        ISSN： 0168-1702            Impact factor:   3.303


× No keyword cloud information.
  162 in total

1.  Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras.

Authors:  R Carroll; L Martarano; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Detection of proviral DNA in horse cells infected with equine infectious anemia virus.

Authors:  N R Rice; S Simek; O A Ryder; L Coggins
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

3.  Role of the host immune response in selection of equine infectious anemia virus variants.

Authors:  S Carpenter; L H Evans; M Sevoian; B Chesebro
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Antigenic reactivity of the major glycoprotein of equine infectious anemia virus, a retrovirus.

Authors:  R C Montelaro; M West; C J Issel
Journal:  Virology       Date:  1984-07-30       Impact factor: 3.616

5.  Equine infectious anemia: plasma clearance times of passively transferred antibody in foals.

Authors:  S J Burns
Journal:  J Am Vet Med Assoc       Date:  1974-01-01       Impact factor: 1.936

6.  Change in host cell tropism associated with in vitro replication of equine infectious anemia virus.

Authors:  S Carpenter; B Chesebro
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

7.  Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.

Authors:  R M Stephens; J W Casey; N R Rice
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

8.  Structural proteins of equine infectious anemia virus and their antigenic activity.

Authors:  M Nishimura; H Nakajima
Journal:  Am J Vet Res       Date:  1984-01       Impact factor: 1.156

9.  Interaction of West Nile virus with primary murine macrophages: role of cell activation and receptors for antibody and complement.

Authors:  M J Cardosa; S Gordon; S Hirsch; T A Springer; J S Porterfield
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

Review 10.  Molecular biology of the human immunodeficiency virus type 1.

Authors:  W A Haseltine
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191
View more
  27 in total

1.  CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.

Authors:  Chungwon Chung; Robert H Mealey; Travis C McGuire
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

2.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain.

Authors:  Y H Zheng; H Sentsui; T Nakaya; Y Kono; K Ikuta
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.

Authors:  Yan-Dong Tang; Lei Na; Chun-Hui Zhu; Nan Shen; Fei Yang; Xian-Qiu Fu; Yu-Hong Wang; Li-Hua Fu; Jia-Yi Wang; Yue-Zhi Lin; Xue-Feng Wang; Xiaojun Wang; Jian-Hua Zhou; Cheng-Yao Li
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

5.  Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses.

Authors:  R H Mealey; D G Fraser; J L Oaks; G H Cantor; T C McGuire
Journal:  Clin Immunol       Date:  2001-11       Impact factor: 3.969

6.  Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.

Authors:  Chungwon Chung; Robert H Mealey; Travis C McGuire
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

7.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

8.  EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.

Authors:  Lina Covaleda; Frederick J Fuller; Susan L Payne
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

9.  Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.

Authors:  Jörg Zielonka; Ignacio G Bravo; Daniela Marino; Elea Conrad; Mario Perković; Marion Battenberg; Klaus Cichutek; Carsten Münk
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

10.  Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses.

Authors:  D C Sellon; K M Walker; K E Russell; S T Perry; P Covington; F J Fuller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.